Security key
00430K402
- Security type / class
- Equity / CL A NEW
- Total 13F shares
- 5,000
- Total 13F value
- $4,000
- Share change
- -12,500
- SEC-reported price per share
- $0.80
- Number of holders
- 1
- Value change
- -$15,000
- Number of sells
- 1
Report period
Q2 2022
Institutions
1
Top holders
1
ACST full security history
Ownership snapshot
Full 13F holder table
Grace Therapeutics, Inc. SEC filings
Grace Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ACST - ACASTI PHARMA INC - CL A NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rajitha Grace 2018 Irrevo...
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
0/15
Latest evidence
22 Jun 2022
3/4/5
13F
Highest disclosed value: $69,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BANK OF AMERICA CORP /DE/ has the largest disclosed position value at $69K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Disclosed position value
Top 5
BANK OF AMERICA CORP /DE/
$69K
MORGAN STANLEY
$66K
NATIONAL BANK OF CANADA /FI/
$22K
GEODE CAPITAL MANAGEMENT, LLC
$22K
EDMOND DE ROTHSCHILD HOLDING S.A.
$15K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rajitha Grace 2018 Irrevocable Trust |
3/4/5
10%+ Owner
|
—
denominator unverified
|
—
4,689,547 shares
|
— | 27 Aug 2021 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
—
denominator unverified
|
$69,000
56,583 shares
|
— | 31 Mar 2022 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$66,000
54,258 shares
|
— | 31 Mar 2022 |
| NATIONAL BANK OF CANADA /FI/ |
13F
Company
|
—
denominator unverified
|
$22,000
18,418 shares
|
— | 31 Mar 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$22,000
18,348 shares
|
— | 31 Mar 2022 |
| EDMOND DE ROTHSCHILD HOLDING S.A. |
13F
Company
|
—
denominator unverified
|
$15,000
12,500 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
5,000
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
2
Q2 2022 holders
1
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|